| 1 | Effect on neutrophil migration and antimicrobial functions by the Bruton's tyrosine kinase inhibitors tolebrutinib, evobrutinib, and fenebrutinib | 3.0 | 5 | Citations (PDF) |
| 2 | Functional Interactions Between Recombinant Serum Amyloid A1 (SAA1) and Chemokines in Leukocyte Recruitment | 4.5 | 1 | Citations (PDF) |
| 3 | Role of Defensins in Tumor Biology | 4.5 | 32 | Citations (PDF) |
| 4 | Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders | 4.5 | 21 | Citations (PDF) |
| 5 | CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy | 4.5 | 15 | Citations (PDF) |
| 6 | Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease | 1.8 | 30 | Citations (PDF) |
| 7 | Tissue Inhibitor of Metalloproteinase-3 Ameliorates Diabetes-Induced Retinal Inflammation | 3.0 | 12 | Citations (PDF) |
| 8 | Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide | 3.7 | 2 | Citations (PDF) |
| 9 | Method Matters: Effect of Purification Technology on Neutrophil Phenotype and Function | 5.0 | 56 | Citations (PDF) |
| 10 | Affinity and Specificity for Binding to Glycosaminoglycans Can Be Tuned by Adapting Peptide Length and Sequence | 4.5 | 12 | Citations (PDF) |
| 11 | Absence of CCR2 Promotes Proliferation of Alveolar Macrophages That Control Lung Inflammation in Acute Respiratory Distress Syndrome in Mice | 4.5 | 7 | Citations (PDF) |
| 12 | Citrullination as a novel posttranslational modification of matrix metalloproteinases | 4.6 | 30 | Citations (PDF) |
| 13 | Studying Neutrophil Function in vitro: Cell Models and Environmental Factors | 3.6 | 121 | Citations (PDF) |
| 14 | The turning away of serum amyloid A biological activities and receptor usage | 4.8 | 34 | Citations (PDF) |
| 15 | Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy | 5.0 | 37 | Citations (PDF) |
| 16 | Phenotypical and Functional Characterization of Neutrophils in Two Pyrin-Associated Auto-inflammatory Diseases | 3.4 | 9 | Citations (PDF) |
| 17 | From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8 | 5.0 | 11 | Citations (PDF) |
| 18 | The Antimicrobial Activity of Peripheral Blood Neutrophils Is Altered in Patients with Primary Ciliary Dyskinesia | 4.5 | 8 | Citations (PDF) |
| 19 | The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer | 4.1 | 19 | Citations (PDF) |
| 20 | Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019 | 3.7 | 44 | Citations (PDF) |
| 21 | The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors | 4.1 | 22 | Citations (PDF) |
| 22 | New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease | 2.7 | 27 | Citations (PDF) |
| 23 | Local Cytokine Expression Profiling in Patients with Specific Autoimmune Uveitic Entities | 1.8 | 32 | Citations (PDF) |
| 24 | Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case | 3.6 | 5 | Citations (PDF) |
| 25 | CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems | 5.0 | 33 | Citations (PDF) |
| 26 | Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1 | 5.0 | 44 | Citations (PDF) |
| 27 | Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS) | 4.5 | 91 | Citations (PDF) |
| 28 | Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1β and Interferon-γ in Liver Bystander Cells | 1.8 | 5 | Citations (PDF) |
| 29 | The ectoenzyme-side of matrix metalloproteinases (MMPs) makes inflammation by serum amyloid A (SAA) and chemokines go round | 2.4 | 14 | Citations (PDF) |
| 30 | Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection | 10.6 | 28 | Citations (PDF) |
| 31 | Human DOCK2 Deficiency: Report of a Novel Mutation and Evidence for Neutrophil Dysfunction | 3.4 | 39 | Citations (PDF) |
| 32 | Expression of interleukin (<scp>IL</scp>)‐10 family cytokines in aqueous humour of patients with specific endogenous uveitic entities: elevated levels of <scp>IL</scp>‐19 in human leucocyte antigen‐B27‐associated uveitis | 0.9 | 19 | Citations (PDF) |
| 33 | The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy | 5.0 | 62 | Citations (PDF) |
| 34 | The <scp>CC</scp> chemokines <scp>CCL</scp>8, <scp>CCL</scp>13 and <scp>CCL</scp>20 are local inflammatory biomarkers of <scp>HLA</scp>‐B27‐associated uveitis | 0.9 | 30 | Citations (PDF) |
| 35 | Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis | 2.2 | 11 | Citations (PDF) |
| 36 | Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras | 4.7 | 11 | Citations (PDF) |
| 37 | Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation in vivo and Anti-HIV-1 Activity | 5.0 | 6 | Citations (PDF) |
| 38 | Chemokine-Induced Macrophage Polarization in Inflammatory Conditions | 5.0 | 399 | Citations (PDF) |
| 39 | Pathological roles of the homeostatic chemokine CXCL12 | 10.6 | 166 | Citations (PDF) |
| 40 | Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands | 5.0 | 276 | Citations (PDF) |
| 41 | Matrix Metalloproteinase-9-Generated COOH-, but Not NH2-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity | 5.0 | 16 | Citations (PDF) |
| 42 | Anti‐inflammatory effects of the <scp>GAG</scp>‐binding <scp>CXCL</scp>9(74‐103) peptide in dinitrofluorobenzene‐induced contact hypersensitivity in mice | 2.6 | 10 | Citations (PDF) |
| 43 | Differential CXC and CX3C Chemokine Expression Profiles in Aqueous Humor of Patients With Specific Endogenous Uveitic Entities 2018, 59, 2222 | | 45 | Citations (PDF) |
| 44 | CXCL4 and CXCL4L1 in cancer | 3.5 | 37 | Citations (PDF) |
| 45 | How post-translational modifications influence the biological activity of chemokines | 3.5 | 64 | Citations (PDF) |
| 46 | Recombinant Parvoviruses Armed to Deliver CXCL4L1 and CXCL10 Are Impaired in Their Antiangiogenic and Antitumoral Effects in a Kaposi Sarcoma Tumor Model Due To the Chemokines' Interference with the Virus Cycle | 3.3 | 10 | Citations (PDF) |
| 47 | Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes | 5.2 | 44 | Citations (PDF) |
| 48 | Relative distribution and biological characterization of CXCL4L1 isoforms in platelets from healthy donors | 5.2 | 4 | Citations (PDF) |
| 49 | Tumor angiogenesis revisited: Regulators and clinical implications | 13.4 | 164 | Citations (PDF) |
| 50 | Chemokine isoforms and processing in inflammation and immunity | 6.8 | 72 | Citations (PDF) |
| 51 | CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions | 5.0 | 38 | Citations (PDF) |
| 52 | Neutrophils from Patients with Primary Ciliary Dyskinesia Display Reduced Chemotaxis to CXCR2 Ligands | 5.0 | 14 | Citations (PDF) |
| 53 | Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy 2017, 58, 3189 | | 36 | Citations (PDF) |
| 54 | The unique structural and functional features of CXCL12 | 14.4 | 336 | Citations (PDF) |
| 55 | Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases | 14.4 | 33 | Citations (PDF) |
| 56 | Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults | 2.5 | 222 | Citations (PDF) |
| 57 | The Cytokine Interleukin-6 and the Chemokines CCL20 and CXCL13 Are Novel Biomarkers of Specific Endogenous Uveitic Entities 2016, 57, 4606 | | 45 | Citations (PDF) |
| 58 | Transforming Growth Factor Beta Switch in Aqueous Humor of Patients With Fuchs' Endothelial Corneal Dystrophy 2016, 57, 771 | | 14 | Citations (PDF) |
| 59 | The cytokine-serum amyloid A-chemokine network | 10.6 | 132 | Citations (PDF) |
| 60 | CD26/dipeptidylpeptidase IV—chemokine interactions: double-edged regulation of inflammation and tumor biology | 3.0 | 96 | Citations (PDF) |
| 61 | CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis | 2.5 | 45 | Citations (PDF) |
| 62 | Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity <i>in vitro</i> and abrogates intra-articular lymphocyte recruitment <i>in vivo</i> | 1.7 | 36 | Citations (PDF) |
| 63 | Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT) | 2.5 | 90 | Citations (PDF) |
| 64 | The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood–Retinal Barrier Breakdown 2015, 56, 1956 | | 17 | Citations (PDF) |
| 65 | Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils | 3.0 | 46 | Citations (PDF) |
| 66 | Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines | 3.4 | 63 | Citations (PDF) |
| 67 | CXCR3 ligands in disease and therapy | 10.6 | 281 | Citations (PDF) |
| 68 | CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase | 7.5 | 25 | Citations (PDF) |
| 69 | Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells | 1.1 | 71 | Citations (PDF) |
| 70 | Angiostatic, tumor inflammatory and anti-tumor effects of CXCL447-70 and CXCL4L147–70 in an EGF-dependent breast cancer model | 1.7 | 29 | Citations (PDF) |
| 71 | Pathogenesis of malaria-associated acute respiratory distress syndrome | 3.3 | 94 | Citations (PDF) |
| 72 | Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis | 2.3 | 13 | Citations (PDF) |
| 73 | Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy | 2.5 | 84 | Citations (PDF) |
| 74 | Identification and characterization of MIP-1α/CCL3 isoform 2 from bovine serum as a potent monocyte/dendritic cell chemoattractant | 5.2 | 18 | Citations (PDF) |
| 75 | CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model | 3.0 | 63 | Citations (PDF) |
| 76 | Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy | 2.5 | 40 | Citations (PDF) |
| 77 | Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment | 4.7 | 51 | Citations (PDF) |
| 78 | Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response | 2.4 | 61 | Citations (PDF) |
| 79 | Cytokine and CXC chemokine expression patterns in aqueous humor of patients with presumed tuberculous uveitis | 3.5 | 35 | Citations (PDF) |
| 80 | The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer | 7.1 | 98 | Citations (PDF) |
| 81 | PF-4var/CXCL4L1 Predicts Outcome in Stable Coronary Artery Disease Patients with Preserved Left Ventricular Function | 2.5 | 22 | Citations (PDF) |
| 82 | PS2-046. New developments in mouse cytokine auto-vaccination with particular emphasis on anti- GCP-2/CXCL6 | 3.5 | 0 | Citations (PDF) |
| 83 | The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer | 10.6 | 161 | Citations (PDF) |
| 84 | The expression and role of CXC chemokines in colorectal cancer | 10.6 | 120 | Citations (PDF) |
| 85 | Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis | 8.5 | 58 | Citations (PDF) |
| 86 | Circulating bone‐marrow‐derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes | 0.9 | 41 | Citations (PDF) |
| 87 | CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis | 1.1 | 49 | Citations (PDF) |
| 88 | Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3Blood, 2011, 117, 480-488 | 1.0 | 99 | Citations (PDF) |
| 89 | Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis | 2.9 | 139 | Citations (PDF) |
| 90 | Longitudinal changes in gingival crevicular fluid after placement of fixed orthodontic appliances | 1.8 | 42 | Citations (PDF) |
| 91 | CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual‐tropic (R5/X4) HIV‐1 infection | 3.4 | 67 | Citations (PDF) |
| 92 | Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in<i>L. major</i>infection | 3.0 | 30 | Citations (PDF) |
| 93 | Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder? | 0.9 | 21 | Citations (PDF) |
| 94 | The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth <i>In vivo</i> | 2.9 | 42 | Citations (PDF) |
| 95 | Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer | 2.4 | 23 | Citations (PDF) |
| 96 | Citrullination of CXCL12 Differentially Reduces CXCR4 and CXCR7 Binding with Loss of Inflammatory and Anti-HIV-1 Activity via CXCR4 | 0.6 | 89 | Citations (PDF) |
| 97 | Recognition Versus Adaptive Up-regulation and Degradation of CC Chemokines by the Chemokine Decoy Receptor D6 Are Determined by Their N-terminal Sequence | 2.3 | 51 | Citations (PDF) |
| 98 | CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8 | 3.0 | 24 | Citations (PDF) |
| 99 | Contribution of intracellular Ca2+ stores to Ca2+ signaling during chemokinesis of human neutrophil granulocytes | 3.6 | 15 | Citations (PDF) |
| 100 | Synergistic up‐regulation of MCP‐2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti‐tumoral effects | 3.4 | 60 | Citations (PDF) |
| 101 | Carcinoma cell‐derived chemokines and their presence in oral fluid | 1.8 | 31 | Citations (PDF) |
| 102 | Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes | 1.1 | 45 | Citations (PDF) |
| 103 | CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN‐γ‐induced chemokines | 3.4 | 105 | Citations (PDF) |
| 104 | The role of CXC chemokines and their receptors in cancer | 8.5 | 592 | Citations (PDF) |
| 105 | Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation | 8.1 | 167 | Citations (PDF) |
| 106 | Synergy between Coproduced CC and CXC Chemokines in Monocyte Chemotaxis through Receptor-Mediated Events | 2.8 | 112 | Citations (PDF) |
| 107 | Platelet Factor-4 Variant Chemokine CXCL4L1 Inhibits Melanoma and Lung Carcinoma Growth and Metastasis by Preventing Angiogenesis | 0.6 | 109 | Citations (PDF) |
| 108 | Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells | 3.0 | 33 | Citations (PDF) |
| 109 | Protective role of IFN-γ in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production | 3.0 | 41 | Citations (PDF) |
| 110 | Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration | 1.0 | 122 | Citations (PDF) |
| 111 | MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells | 4.5 | 44 | Citations (PDF) |
| 112 | The role of chemokines and their receptors in uveitis | 1.3 | 5 | Citations (PDF) |
| 113 | Title is missing! | 4.1 | 65 | Citations (PDF) |
| 114 | The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage | 2.5 | 46 | Citations (PDF) |
| 115 | TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis | 3.7 | 101 | Citations (PDF) |
| 116 | Structure/Function Relationships of CCR8 Agonists and Antagonists | 2.3 | 33 | Citations (PDF) |
| 117 | Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue | 3.4 | 92 | Citations (PDF) |
| 118 | GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors | 3.2 | 157 | Citations (PDF) |
| 119 | Synergy in cytokine and chemokine networks amplifies the inflammatory response | 10.6 | 195 | Citations (PDF) |
| 120 | Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration | 3.0 | 109 | Citations (PDF) |
| 121 | Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis | 11.3 | 158 | Citations (PDF) |
| 122 | Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-γ in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids | 3.0 | 86 | Citations (PDF) |
| 123 | Chemokine–protease interactions in cancer | 14.3 | 67 | Citations (PDF) |
| 124 | Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6 | 5.2 | 6 | Citations (PDF) |
| 125 | CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue | 3.4 | 70 | Citations (PDF) |
| 126 | Chemokines and gelatinases in the aqueous humor of patients with active uveitis | 3.5 | 51 | Citations (PDF) |
| 127 | CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/CCL1 and vMIP-I | 3.4 | 58 | Citations (PDF) |
| 128 | Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-γ and provide a mechanism for enhanced synovial chemokine levels in septic arthritis | 3.4 | 104 | Citations (PDF) |
| 129 | The CXC Chemokine GCP-2/CXCL6 Is Predominantly Induced in Mesenchymal Cells by Interleukin-1β and Is Down-Regulated by Interferon-γ: Comparison with Interleukin-8/CXCL8 | 3.7 | 90 | Citations (PDF) |
| 130 | The T-lymphocyte chemoattractant Mig is highly expressed in vernal keratoconjunctivitis | 3.5 | 22 | Citations (PDF) |
| 131 | PARC/CCL18 Is a Plasma CC Chemokine with Increased Levels in Childhood Acute Lymphoblastic Leukemia | 3.5 | 78 | Citations (PDF) |
| 132 | The CC chemokine CCL20 and its receptor CCR6 | 10.6 | 731 | Citations (PDF) |
| 133 | Regulation of the Immune Response by the Interaction of Chemokines and Proteases | 0.0 | 106 | Citations (PDF) |
| 134 | Unique Regulation of CCL18 Production by Maturing Dendritic Cells | 0.6 | 148 | Citations (PDF) |
| 135 | Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation | 2.3 | 1,475 | Citations (PDF) |
| 136 | Role of Chemokines in Vernal Keratoconjunctivitis | 0.6 | 14 | Citations (PDF) |
| 137 | Natural Substrates of Dipeptidyl Peptidase IV | 8.0 | 76 | Citations (PDF) |
| 138 | The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure | 2.8 | 29 | Citations (PDF) |
| 139 | Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma | 2.3 | 198 | Citations (PDF) |
| 140 | Gene Cloning of a New Plasma CC Chemokine, Activating and Attracting Myeloid Cells in Synergy with Other Chemoattractants†,‡ | 2.9 | 17 | Citations (PDF) |
| 141 | Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1Blood, 2001, 97, 2197-2204 | 1.0 | 43 | Citations (PDF) |
| 142 | Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic propertiesBlood, 2001, 98, 3554-3561 | 1.0 | 231 | Citations (PDF) |
| 143 | Dendritic cells as a major source of macrophage-derived chemokine/CCL22in vitro andin vivo | 3.4 | 255 | Citations (PDF) |
| 144 | Diverging binding capacities of natural LD78β isoforms of macrophage inflammatory protein-1α to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils | 3.4 | 95 | Citations (PDF) |
| 145 | Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis | 3.4 | 57 | Citations (PDF) |
| 146 | The LD78β Isoform of MIP-1α Is the Most Potent CC-Chemokine in Inhibiting CCR5-Dependent Human Immunodeficiency Virus Type 1 Replication in Human Macrophages | 3.6 | 50 | Citations (PDF) |
| 147 | Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonistBlood, 2000, 96, 1674-1680 | 1.0 | 153 | Citations (PDF) |
| 148 | Regulated Production and Molecular Diversity of Human Liver and Activation-Regulated Chemokine/Macrophage Inflammatory Protein-3α from Normal and Transformed Cells | 0.6 | 82 | Citations (PDF) |
| 149 | Biochemical and Biological Characterization of Neutrophil Chemotactic Protein, a Novel Rabbit CXC Chemokine from Alveolar Macrophages | 2.9 | 10 | Citations (PDF) |
| 150 | Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor | 2.8 | 108 | Citations (PDF) |
| 151 | cis Requirements for the Efficient Production of Recombinant DNA Vectors Based on Autonomous Parvoviruses | 3.3 | 84 | Citations (PDF) |
| 152 | Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction | 2.3 | 142 | Citations (PDF) |
| 153 | Isolation of the CXC chemokines ENA-78, GROα and GROγ from tumor cells and leukocytes reveals NH2-terminal heterogeneity | 0.2 | 78 | Citations (PDF) |
| 154 | Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-α / β and interferon-γ reveals MCP-3 heterogeneity | 3.4 | 65 | Citations (PDF) |
| 155 | Synthesis and Structure−Activity Relationships of Phenylenebis(methylene)- Linked Bis-azamacrocycles That Inhibit HIV-1 and HIV-2 Replication by Antagonism of the Chemokine Receptor CXCR4 | 6.9 | 112 | Citations (PDF) |
| 156 | The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1–inhibiting chemokine | 9.1 | 93 | Citations (PDF) |
| 157 | CD26-processed RANTES(3–68), but not intact RANTES, has potent anti-HIV-1 activity | 3.8 | 75 | Citations (PDF) |
| 158 | Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor | 3.4 | 134 | Citations (PDF) |
| 159 | Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α | 2.8 | 190 | Citations (PDF) |
| 160 | Functional Comparison of Two Human Monocyte Chemotactic Protein-2 Isoforms, Role of the Amino-Terminal Pyroglutamic Acid and Processing by CD26/Dipeptidyl Peptidase IV† | 2.9 | 148 | Citations (PDF) |
| 161 | Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV | 2.3 | 242 | Citations (PDF) |
| 162 | Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 | 8.1 | 575 | Citations (PDF) |
| 163 | Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage | 3.0 | 99 | Citations (PDF) |
| 164 | Isolation of human monocyte chemotactic proteins and study of their producer and responder cells by immunotests and bioassays | 0.0 | 3 | Citations (PDF) |
